Disclosure Of Interests In Other Entities [Text Block]

Egetis Therapeutics - Filing #701621

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	152 902 SEK	—	—	—	—	—	—	299 871 SEK	—	—	—	—	—
Non-current assets	416 366 SEK	—	—	—	—	—	—	417 130 SEK	—	—	—	—	—
Current liabilities	39 170 SEK	—	—	—	—	—	—	70 141 SEK	—	—	—	—	—
Non-current liabilities	3 060 SEK	—	—	—	—	—	—	16 135 SEK	—	—	—	—	—
Revenue	—	—	—	—	38 243 SEK	—	—	—	—	40 662 SEK	—	—	—
Profit (loss)	—	—	—	—	104 542 SEK	—	—	—	—	178 024 SEK	—	—	—
Comprehensive income	—	– SEK	– SEK	– SEK	104 542 SEK	104 542 SEK	178 024 SEK	—	– SEK	178 024 SEK	– SEK	– SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	—	—	—	- SEK	—	—	—	—	- SEK	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	143 965 SEK	—	—	—	—	—	—	287 850 SEK	—	—	—	—	255 101 SEK
Tax expense (income)	—	—	—	—	- SEK	—	—	—	—	- SEK	—	—	—